OTC Markets OTCQB - Delayed Quote USD

Telo Genomics Corp. (TDSGF)

0.0700
+0.0050
+(7.69%)
At close: June 5 at 8:00:00 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
2,611.3430
2,723.0100
2,820.7720
2,110.4540
1,257.1970
Operating Income
-2,611.3430
-2,723.0100
-2,820.7720
-2,110.4540
-1,257.1970
Net Non Operating Interest Income Expense
--
--
--
--
0
Other Income Expense
--
10
--
--
187.2340
Pretax Income
-2,611.3430
-2,713.0100
-2,820.7720
-2,110.4540
-1,069.9630
Net Income Common Stockholders
-2,611.3430
-2,713.0100
-2,820.7720
-2,110.4540
-1,069.9630
Diluted NI Available to Com Stockholders
-2,611.3430
-2,713.0100
-2,820.7720
-2,110.4540
-1,069.9630
Basic EPS
-0.03
-0.04
-0.05
-0.04
-0.02
Diluted EPS
-0.03
-0.04
-0.05
-0.04
-0.02
Basic Average Shares
80,650.9440
71,384.1130
60,152.2780
58,661.0880
46,888.8650
Diluted Average Shares
80,650.9440
71,384.1130
60,152.2780
58,661.0880
46,888.8650
Total Expenses
2,611.3430
2,723.0100
2,820.7720
2,110.4540
1,257.1970
Net Income from Continuing & Discontinued Operation
-2,611.3430
-2,713.0100
-2,820.7720
-2,110.4540
-1,069.9630
Normalized Income
-2,611.3430
-2,723.0100
-2,820.7720
-2,110.4540
-1,257.1970
Interest Expense
--
--
--
--
0
Net Interest Income
--
--
--
--
0
EBIT
-2,611.3430
-2,723.0100
-2,820.7720
-2,110.4540
-1,257.1970
EBITDA
-2,590.9590
-2,683.4740
-2,787.6580
-2,053.4980
-1,194.9690
Reconciled Depreciation
20.3840
39.5360
33.1140
56.9560
62.2280
Net Income from Continuing Operation Net Minority Interest
-2,611.3430
-2,713.0100
-2,820.7720
-2,110.4540
-1,069.9630
Total Unusual Items Excluding Goodwill
0
10
0
0
187.2340
Total Unusual Items
0
10
0
0
187.2340
Normalized EBITDA
-2,590.9590
-2,693.4740
-2,787.6580
-2,053.4980
-1,382.2030
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade